¿Qué es el aclaramiento esofágico? ¿Cuáles son los factores agresivos? ¿Cuál es el rol de la Hernia del Hiato? ¿Qué factores de riesgo/protección se asocian. dr marugán tema reflujo gastroesofágico el reflujo es una cuestión de cantidad, todos tenemos reflujo pero cuando ese paso de contenido gástrico es mayor de . mediante pH-metría ambulatoria de 24 horas y un estudio isotópico con radionúclidos para determinar el aclaramiento esofágico de líquidos a largo plazo.
|Published (Last):||13 September 2011|
|PDF File Size:||18.84 Mb|
|ePub File Size:||5.43 Mb|
|Price:||Free* [*Free Regsitration Required]|
Both Female Only Male Only. Johns Wort and other herbal supplements known to induce CYP3A4 less than 14 days prior to study day 1.
Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis. Br J Surg, 84pp. To evaluate the effectiveness of the Angelchik prosthesis in controlling gastroesophageal reflux and its effect on esophageal function in the long term.
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
Evaluation of Angelchik antireflux prosthesis: The role of the esophageal body in the antireflux mechanism. Of 15 patients who underwent pH-metry, only one presented reflux. Se continuar a navegar, consideramos que aceita o seu uso.
Currently receiving any anti-tumor treatments, or less than 14 days prior to enrollment since ending anti-tumor treatment. Cir Esp, 42pp. Combination product that includes a device, but does not involve an Advanced Therapy. Br J Surg, 71pp. Reflux oesophagitis and esophageal transit: Clear advanced search filters.
World J Surg, 26pp. Testing may be performed by central laboratory prior to main study informed consent if subject signs a separate consent for the purposes of tumor tissue testing – Availability of recent preferred or archival tumor tissue – Measurable disease per RECIST 1. IMP with orphan designation in the indication. The results were grouped into three periods: New complications associated with the Angelchik prosthesis. Eeofagico, 40pp.
Prospective evaluation of patiens with tipical syntoms. Scand J Gastroenterol, 27pp. Si continua navegando, consideramos que acepta su uso. Digest Dis Sci, 37pp. World J Surg, 24pp.
Am J Surg,pp. Cancer AND drug name. The Aclaraimento prosthesis produces a sustained long-term improvement in LES function with few adverse effects on esophageal body dynamics or the upper esophageal sphincter. There was also an improvement in the motility of the esophageal body in the last evaluation compared with preoperative values. The Angelchik prosthesis behaves as a fundoplication. Twenty-six patients who underwent implantation of an Angelchik prosthesis between March and June were prospectively followed-up months, median by means of a questionnaire, barium contrast, endoscopy, and manometric studies.
Long-term results of the Angelchik prosthesis for gastroesophageal reflux. EU Clinical Trials Register. Br J Surg, 72pp. Esophageal, Gastroesophageal Junction and Gastric Cancer.
Of 15 patients who underwent pH-metry, only one presented reflux. Gastroenterology, 83pp. Rev Esp Enf Ap Dig, 64pp. Functional results after a ten-year follow-up. A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia.
Subscribe to our Newsletter. Lancet, aclarmaiento, pp. Outcomes of laparoscopic antireflux procedures. Pneumonia AND sponsor name. Prospective randomized trial of Nissen fundoplication and Angelchick prosthesis in the surgical treatment of medically refractory gastroesophageal reflux disease.
CiteScore measures average citations received per document published. Br Aclaraminto Surg, 88pp. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Br J Surg, 80pp. Are you a health professional able to prescribe or dispense drugs? How to search [pdf].